Amkay Products Limited Files Quarterly Compliance Certificate for Q4 FY26

Amkay Products Limited has filed its quarterly compliance certificate with BSE Limited for the quarter and year ended 31st March, 2026. The submission fulfills the company's regulatory obligations under SEBI (Depositories and Participants) Regulations, 2018.

Regulatory Compliance Certificate

The certificate was issued under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. Bigshare Services Pvt. Ltd., serving as the company's Registrar and Share Transfer Agent, provided the compliance confirmation to Amkay Products Limited.

Parameter:	Details
Regulation:	SEBI Regulation 74(5)
Quarter Ended:	31st March, 2026
Registrar:	Bigshare Services Pvt. Ltd.
BSE Scrip Code:	544169

Share Holding Status

According to the certificate issued by Bigshare Services Pvt. Ltd., the regulation is not applicable to the company as the entire holding of Amkay Products Limited's shares are maintained in demat form. The registrar confirmed that no requests were received from any members of the company for rematerialisation during the quarter ended 31st March, 2026.

Corporate Information

Amkay Products Limited operates as a manufacturer of medical devices and disposables. The company holds CE ISO 13485:2016 certification and maintains its registered office at Amkay Enclave, 68, Rashmi Park Bungalow, Dhumaal Nagar, Waliv Road, Vasai (East), Palghar, Maharashtra.

Authorisation Details

The compliance certificate was signed by Kashyap Pravin Mody, Managing Director of Amkay Products Limited (DIN: 01717036), and submitted to BSE Limited on 06/04/2026. Akash Shamal, Authorised Signatory from Bigshare Services Pvt. Ltd., authenticated the registrar's certificate confirming the demat status of all shareholdings.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-4.72%	-11.69%	-2.54%	+28.00%	+23.42%	-49.37%

Amkay Products Limited has announced a mandatory trading window closure for all designated persons, effective from April 1, 2026. The closure will remain in effect until 48 hours after the company declares its financial results for the financial year ended March 31, 2026.

Regulatory Compliance Details

The trading window closure is implemented in strict adherence to regulatory requirements. The company has cited compliance with SEBI (Prohibition of Insider Trading) Regulation, 2015, read with BSE Circular No. LIST/COMP/01/2019-20 dated April 2, 2019, as the basis for this action.

Parameter:	Details
Effective Date:	April 1, 2026
Closure Duration:	Until 48 hours after FY26 results declaration
Applicable To:	All Designated Persons
Regulatory Framework:	SEBI Insider Trading Regulations 2015
BSE Circular Reference:	LIST/COMP/01/2019-20 dated April 2, 2019

Company Background

Amkay Products Limited operates as a manufacturer of medical devices and disposables. The company maintains its registered office at Amkay Enclave, 68, Rashmi Park Bungalow, Dhumaal Nagar, Waliv Road, Vasai (East), Palghar - 401208, Maharashtra, India. The company holds ISO 9001:2015 certification and operates under the corporate identity number U51397MH2007PLC175403.

Official Communication

The formal intimation was communicated to BSE Limited on March 25, 2026, through an official letter signed by Kashyap Pravin Mody, Managing Director (DIN: 01717036). The communication was digitally signed and addressed to the Deputy General Manager, Corporate Relationship Department at BSE Limited.

Trading Window Implications

During the closure period, designated persons within the company will be restricted from trading in the company's securities. This measure ensures compliance with insider trading regulations and maintains market integrity during the period leading up to and immediately following the financial results announcement. The trading window will reopen 48 hours after the official declaration of the company's financial results for FY26.